Lv1
30 积分 2021-12-16 加入
Refining therapeutic targeting of interleukin-6 by signalling mode selectivity
21天前
已完结
A comparison of antibody–antigen complex sequence‐to‐structure prediction methods and their systematic biases
22天前
已完结
Accurate ligand–protein docking in CASP15 using the ClusPro LigTBM server
22天前
已完结
Repositioning TH cell polarization from single cytokines to complex help
2个月前
已完结
How multispecific molecules are transforming pharmacotherapy
3个月前
已完结
Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL‐22 production and IL‐2‐dependent proliferation
4个月前
已完结
TL1A blockade in inflammatory bowel diseases: Clinical trials to watch
5个月前
已完结
Understanding the therapeutic toolkit for inflammatory bowel disease
5个月前
已完结
Hospitalisations and surgery in Crohn's disease
5个月前
已完结
Engineered mucus-tethering bispecific nanobodies enhance mucosal immunity against respiratory pathogens
6个月前
已完结
皖公网安备34019202002308
